Current Oncology, Free Full-Text

Triple-negative breast cancer (TNBC) has a worse prognosis and remains the most challenging breast cancer subtype to treat. This is largely related to the heterogeneity of this disease and the lack of reliable oncological targets. In this review, we discuss the current standard-of-care treatment options for metastatic TNBC, including recent advances with the use of immunotherapy, PARP inhibitors and antibody-drug conjugates. This review also explores new agents and novel combinations arising in the field for the treatment of advanced TNBC.

Current Oncology, Free Full-Text, Skin Tone Construction Paper

New England Employee Benefits Council (NEEBC) on LinkedIn

A Multicentre, Randomised Trial Comparing Schedules Of, 44% OFF

First-line Atezolizumab Monotherapy Versus Single-agent, 43% OFF

Current Oncology, Free Full-Text

Oncology Nursing (@oncologynursing) • Instagram photos and videos

a PDF version of the Full Hematology Oncology Curriculum

Pallimed: 07_05

CancerCare Coping with Stomach Cancer During the Holidays

National Comprehensive Cancer Network - Home

Camp One Step provides free camp experience for kids with cancer

Current Oncology, Free Full-Text

Current Oncology, Free Full-Text

Full Issue PDF Volume 36, Issue 2: Oncology Issues: Vol 36, No 2